COURTNEY POWELL: Open Payments
NPI 1952875544 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 13 payments from 6 companies in 2025. Trend: 2023 $340 · 2024 $0 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $80 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Regeneron Healthcare Solutions, Inc. | 2 | $61 |
| United Therapeutics Corporation | 1 | $34 |
| Verona Pharma, Inc. | 1 | $27 |
| Corium, LLC | 1 | $17 |
Products named: TRELEGY ELLIPTA, DUPIXENT, Tyvaso, TEZSPIRE, Ohtuvayre, FASENRA, Azstarys, NUCALA.
Industry payments across NC — which companies pay providers there.
